Galderma Investigational Site

Boston, Massachusetts 02115

0 studies enrolling now · 3 studies all time

What they study most

Cutaneous T Cell Lymphoma, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) — Completed